secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2025-08-21T23:59:59+00:00
Accession:  0001213900-25-079361
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Oramed shareholders approve 2M-share increase to 2019 stock incentive plan at annual meeting
--------------------------------------------------------------------------------

- Shareholders approved amendment to 2019 Stock Incentive Plan, increasing authorized shares by 2M to 9.5M shares.
- All seven director nominees re-elected; votes ranged from 12.5M to 13.0M for, with broker non-votes of ~6.4M.
- Auditor Kesselman & Kesselman (PwC Israel) ratified for FY2025 with 19.4M for, 1.4M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390025079361/0001213900-25-079361-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390025079361/ea0254007-8k_oramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-079361

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer